LP3 Network Announces Its New Status as a Provider of Continuing Medical Education
AVENTURA, Fla.--(BUSINESS WIRE)--Dec 13, 2018--As an innovative leader in the personalized medicine industry, LP3 Network announced today that beginning in 2019, the company will be a provider of continuing medical education (CME).
LP3 Network’s CME-accredited activities have been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Foundation for Care Management (FCM) and LP3 Network. FCM is accredited by the ACCME to provide continuing medical education for physicians. FCM designates the following educational activities for AMA PRA Category 1 Credits™:Personalized Hormone Restoration Therapy: The Fundamentals https://education.lp3network.com/live-training/HRT Personalized Hormone Restoration Therapy: Advanced Clinical Practice https://education.lp3network.com/live-training/HRT-Advanced Essential Elements of Personalized Analgesic Medication https://education.lp3network.com/live-training/Analgesic
As a fundamental extension of the triad relationship (physician, pharmacist, patient), LP3 Network strives to empower the healthcare community by raising the standards of healthcare through quality education and training. LP3 Network’s innovative continuing education programs are revitalizing personalized medicine practices and pharmaceutical compounding businesses.
“As a first-class provider of continuing education, we are extremely pleased to attain this prestigious accreditation status. This achievement is an attestation of LP3 Network’s long-term commitment to providing the most current, scientifically sound, and evidence-based education to healthcare providers across multiple disciplines,” said Maurizio De Stefano, LP3 Network General Manager.
With patient-centric medicine at the heart of its educational mission, LP3 Network recognizes the fundamental importance of working together with fellow healthcare providers to optimize patient outcomes. Through clinical data and peer-reviewed research, LP3 Network’s programs provide practitioners with the evidence-based approaches needed to manage complex hormone and pain conditions. The program facilitators and leading subject-matter experts who reinforce this evidence through their wealth of knowledge and experience, further distinguish the excellence in quality provided by LP3 Network’s platform of continuing education offerings.
About LP3 Network
LP3 Network is a Global Leader in Continuing Healthcare Education™ that has trained over 12, 000 professionals, with more than 70 live event offerings per year worldwide in the United States, Canada, Australia, New Zealand, Philippines, Brazil, Spain, and Singapore. Its distance-learning platform provides access to quality online continuing education to both students and practicing professionals in over 50 countries worldwide. LP3 Network offers a platform of courses designed to have a positive impact on professional development within the healthcare sector including live events (seminars and laboratory trainings), home studies, webinars, and eLearning.
View source version on businesswire.com:https://www.businesswire.com/news/home/20181213005133/en/
CONTACT: Maurizio De Stefano
KEYWORD: UNITED STATES NORTH AMERICA FLORIDA
INDUSTRY KEYWORD: EDUCATION CONTINUING HEALTH PUBLIC POLICY/GOVERNMENT HEALTHCARE REFORM OTHER HEALTH
SOURCE: LP3 Network
Copyright Business Wire 2018.
PUB: 12/13/2018 09:35 AM/DISC: 12/13/2018 09:35 AM